Because of what Macfarlane said - "we don't know who's on the drug, it's a placebo controlled trial" - and because of the dizziness. Mcfarlane's point, and the story's, was they were likely on the drug, likely getting therapeutic effect, and that there were others.
Market Data 
Markets 
AI
